Logo image of PTVE

PACTIV EVERGREEN INC (PTVE) Stock Fundamental Analysis

NASDAQ:PTVE - Nasdaq - US69526K1051 - Common Stock - Currency: USD

17.77  +0.02 (+0.11%)

After market: 17.77 0 (0%)

Fundamental Rating

3

PTVE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 24 industry peers in the Containers & Packaging industry. PTVE has a bad profitability rating. Also its financial health evaluation is rather negative. PTVE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PTVE had positive earnings in the past year.
PTVE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PTVE reported negative net income in multiple years.
Each year in the past 5 years PTVE had a positive operating cash flow.
PTVE Yearly Net Income VS EBIT VS OCF VS FCFPTVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

1.2 Ratios

PTVE's Return On Assets of -2.76% is on the low side compared to the rest of the industry. PTVE is outperformed by 82.61% of its industry peers.
Looking at the Return On Equity, with a value of -15.39%, PTVE is doing worse than 78.26% of the companies in the same industry.
PTVE's Return On Invested Capital of 6.19% is on the low side compared to the rest of the industry. PTVE is outperformed by 65.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PTVE is below the industry average of 7.70%.
The 3 year average ROIC (2.73%) for PTVE is below the current ROIC(6.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.76%
ROE -15.39%
ROIC 6.19%
ROA(3y)0.38%
ROA(5y)0.26%
ROE(3y)1.84%
ROE(5y)1.48%
ROIC(3y)2.73%
ROIC(5y)2.57%
PTVE Yearly ROA, ROE, ROICPTVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

PTVE's Operating Margin of 9.08% is in line compared to the rest of the industry. PTVE outperforms 43.48% of its industry peers.
PTVE's Operating Margin has declined in the last couple of years.
The Gross Margin of PTVE (18.59%) is worse than 73.91% of its industry peers.
PTVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.08%
PM (TTM) N/A
GM 18.59%
OM growth 3Y-6.61%
OM growth 5Y-16.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y-3.5%
PTVE Yearly Profit, Operating, Gross MarginsPTVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PTVE is destroying value.
PTVE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PTVE has been increased compared to 5 years ago.
PTVE has a better debt/assets ratio than last year.
PTVE Yearly Shares OutstandingPTVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
PTVE Yearly Total Debt VS Total AssetsPTVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that PTVE is in the distress zone and has some risk of bankruptcy.
PTVE has a Altman-Z score of 1.77. This is in the lower half of the industry: PTVE underperforms 69.57% of its industry peers.
PTVE has a debt to FCF ratio of 27.52. This is a negative value and a sign of low solvency as PTVE would need 27.52 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 27.52, PTVE is doing worse than 69.57% of the companies in the same industry.
A Debt/Equity ratio of 3.22 is on the high side and indicates that PTVE has dependencies on debt financing.
With a Debt to Equity ratio value of 3.22, PTVE is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.22
Debt/FCF 27.52
Altman-Z 1.77
ROIC/WACC0.94
WACC6.6%
PTVE Yearly LT Debt VS Equity VS FCFPTVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

PTVE has a Current Ratio of 1.93. This is a normal value and indicates that PTVE is financially healthy and should not expect problems in meeting its short term obligations.
PTVE's Current ratio of 1.93 is fine compared to the rest of the industry. PTVE outperforms 73.91% of its industry peers.
A Quick Ratio of 1.04 indicates that PTVE should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.04, PTVE perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.04
PTVE Yearly Current Assets VS Current LiabilitesPTVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

3

3. Growth

3.1 Past

PTVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1211.11%, which is quite impressive.
Looking at the last year, PTVE shows a decrease in Revenue. The Revenue has decreased by -9.02% in the last year.
The Revenue has been growing slightly by 0.75% on average over the past years.
EPS 1Y (TTM)1211.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y5.53%
Revenue growth 5Y0.75%
Sales Q2Q%-3.34%

3.2 Future

The Earnings Per Share is expected to grow by 157.06% on average over the next years. This is a very strong growth
Based on estimates for the next years, PTVE will show a decrease in Revenue. The Revenue will decrease by -0.90% on average per year.
EPS Next Y1063.48%
EPS Next 2Y281.55%
EPS Next 3Y157.06%
EPS Next 5YN/A
Revenue Next Year-7.04%
Revenue Next 2Y-2.72%
Revenue Next 3Y-0.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PTVE Yearly Revenue VS EstimatesPTVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
PTVE Yearly EPS VS EstimatesPTVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

PTVE is valuated rather expensively with a Price/Earnings ratio of 17.77.
Compared to the rest of the industry, the Price/Earnings ratio of PTVE indicates a slightly more expensive valuation: PTVE is more expensive than 60.87% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of PTVE to the average of the S&P500 Index (28.51), we can say PTVE is valued slightly cheaper.
With a Price/Forward Earnings ratio of 13.56, PTVE is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PTVE is on the same level as its industry peers.
PTVE is valuated cheaply when we compare the Price/Forward Earnings ratio to 93.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.77
Fwd PE 13.56
PTVE Price Earnings VS Forward Price EarningsPTVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

PTVE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PTVE is cheaper than 65.22% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PTVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.1
EV/EBITDA 8.26
PTVE Per share dataPTVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PTVE's earnings are expected to grow with 157.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y281.55%
EPS Next 3Y157.06%

3

5. Dividend

5.1 Amount

PTVE has a Yearly Dividend Yield of 2.25%.
Compared to an average industry Dividend Yield of 3.06, PTVE pays a bit more dividend than its industry peers.
PTVE's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

PTVE has been paying a dividend for less than 5 years, so it still needs to build a track record.
PTVE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
PTVE Yearly Dividends per sharePTVE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

PTVE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-42.51%
EPS Next 2Y281.55%
EPS Next 3Y157.06%
PTVE Yearly Income VS Free CF VS DividendPTVE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

PACTIV EVERGREEN INC

NASDAQ:PTVE (1/30/2025, 8:00:01 PM)

After market: 17.77 0 (0%)

17.77

+0.02 (+0.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners22.81%
Inst Owner Change0.21%
Ins Owners0.56%
Ins Owner Change0.39%
Market Cap3.19B
Analysts74.55
Price Target17.85 (0.45%)
Short Float %2.6%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP-42.51%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.05%
Min EPS beat(2)-33.14%
Max EPS beat(2)-2.95%
EPS beat(4)2
Avg EPS beat(4)19.93%
Min EPS beat(4)-33.14%
Max EPS beat(4)65.09%
EPS beat(8)4
Avg EPS beat(8)-105.3%
EPS beat(12)7
Avg EPS beat(12)-9.28%
EPS beat(16)9
Avg EPS beat(16)15.02%
Revenue beat(2)0
Avg Revenue beat(2)-4.26%
Min Revenue beat(2)-4.85%
Max Revenue beat(2)-3.67%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-3.67%
Revenue beat(8)0
Avg Revenue beat(8)-4.6%
Revenue beat(12)3
Avg Revenue beat(12)-2.09%
Revenue beat(16)6
Avg Revenue beat(16)-0.76%
PT rev (1m)20.69%
PT rev (3m)29.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.55%
EPS NY rev (1m)0%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 17.77
Fwd PE 13.56
P/S 0.61
P/FCF 25.1
P/OCF 8.26
P/B 2.94
P/tB N/A
EV/EBITDA 8.26
EPS(TTM)1
EY5.63%
EPS(NY)1.31
Fwd EY7.37%
FCF(TTM)0.71
FCFY3.98%
OCF(TTM)2.15
OCFY12.11%
SpS28.97
BVpS6.05
TBVpS-9.37
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -15.39%
ROCE 9.08%
ROIC 6.19%
ROICexc 6.4%
ROICexgc 14.22%
OM 9.08%
PM (TTM) N/A
GM 18.59%
FCFM 2.44%
ROA(3y)0.38%
ROA(5y)0.26%
ROE(3y)1.84%
ROE(5y)1.48%
ROIC(3y)2.73%
ROIC(5y)2.57%
ROICexc(3y)2.9%
ROICexc(5y)2.76%
ROICexgc(3y)5.8%
ROICexgc(5y)5.22%
ROCE(3y)4.01%
ROCE(5y)3.77%
ROICexcg growth 3Y0.74%
ROICexcg growth 5Y-6.61%
ROICexc growth 3Y-0.19%
ROICexc growth 5Y1.49%
OM growth 3Y-6.61%
OM growth 5Y-16.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y-3.5%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 3.22
Debt/FCF 27.52
Debt/EBITDA 4.43
Cap/Depr 81.96%
Cap/Sales 4.98%
Interest Coverage 2.11
Cash Conversion 48.98%
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.04
Altman-Z 1.77
F-Score4
WACC6.6%
ROIC/WACC0.94
Cap/Depr(3y)68.53%
Cap/Depr(5y)78.24%
Cap/Sales(3y)4.84%
Cap/Sales(5y)7.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1211.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y1063.48%
EPS Next 2Y281.55%
EPS Next 3Y157.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y5.53%
Revenue growth 5Y0.75%
Sales Q2Q%-3.34%
Revenue Next Year-7.04%
Revenue Next 2Y-2.72%
Revenue Next 3Y-0.9%
Revenue Next 5YN/A
EBIT growth 1Y206.49%
EBIT growth 3Y-1.45%
EBIT growth 5Y-15.41%
EBIT Next Year85.74%
EBIT Next 3Y27.55%
EBIT Next 5YN/A
FCF growth 1Y111.67%
FCF growth 3YN/A
FCF growth 5Y-7.67%
OCF growth 1Y23.72%
OCF growth 3Y28.27%
OCF growth 5Y-11.12%